scispace - formally typeset
N

Nelson Gaburo

Researcher at University of São Paulo

Publications -  7
Citations -  1717

Nelson Gaburo is an academic researcher from University of São Paulo. The author has contributed to research in topics: Lineage (genetic) & Pandemic. The author has an hindex of 5, co-authored 6 publications receiving 893 citations.

Papers
More filters
Journal ArticleDOI

Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil.

Nuno R. Faria, +74 more
- 21 May 2021 - 
TL;DR: In this article, the authors used a two-category dynamical model that integrates genomic and mortality data to estimate that P.1 may be 1.7-to 2.4-fold more transmissible and that previous (non-P.1) infection provides 54 to 79% of the protection against infection with P.
Journal ArticleDOI

Evolution and epidemic spread of SARS-CoV-2 in Brazil.

Darlan da Silva Candido, +85 more
- 23 Jul 2020 - 
TL;DR: New light is shed on the epidemic transmission and evolutionary trajectories of SARS-CoV-2 lineages in Brazil and evidence that current interventions remain insufficient to keep virus transmission under control in this country is provided.
Posted ContentDOI

Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil

Nuno R. Faria, +74 more
- 03 Mar 2021 - 
TL;DR: In this paper, the emergence and circulation of a new SARS-CoV-2 variant of concern, lineage P.1, that acquired 17 mutations, including a trio in the spike protein (K417T, E484K and N501Y) associated with increased binding to the human ACE2 receptor.

Data from: Evolution and epidemic spread of SARS-CoV-2 in Brazil

Darlan da Silva Candido, +77 more
TL;DR: New light is shed on the epidemic transmission and evolutionary trajectories of SARS-CoV-2 lineages in Brazil, and evidence that current interventions remain insufficient to keep virus transmission under control in the country is provided.
Journal ArticleDOI

Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study.

TL;DR: In this article, the neutralizing effects of antibodies on lineage P.1 and lineage B isolates of SARS-CoV-2, using plasma samples from patients previously infected with or vaccinated against SARS CoV2, were investigated.